FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386470026> ?p ?o ?g. }

• W4386470026 endingPage "109705" @default.
• W4386470026 startingPage "109705" @default.
• W4386470026 abstract "Volatile anesthetics alter presynaptic function through effects on Ca2+ influx and neurotransmitter release. These actions are proposed to play important roles in their pleiotropic neurophysiological effects including immobility, unconsciousness and amnesia. Nitric oxide and cyclic guanosine monophosphate (NO/cGMP) signaling has been implicated in presynaptic mechanisms, and disruption of NO/cGMP signaling has been shown to alter sensitivity to volatile anesthetics in vivo. We investigated volatile anesthetic actions NO/cGMP signaling in relation to presynaptic function in cultured rat hippocampal neurons using pharmacological tools and genetically encoded biosensors and sequestering probes of cGMP levels. Using the fluorescent cGMP biosensor cGull, we found that electrical stimulation-evoked NMDA-type glutamate receptor-independent presynaptic cGMP transients were inhibited 33.2% by isoflurane (0.51 mM) and 26.4% by sevoflurane (0.57 mM) (p < 0.0001) compared to control stimulation without anesthetic. Stimulation-evoked cGMP transients were blocked by the nonselective inhibitor of nitric oxide synthase N-ω-nitro-l-arginine, but not by the selective neuronal nitric oxide synthase inhibitor N5-(1-imino-3-butenyl)-l-ornithine. Isoflurane and sevoflurane inhibition of stimulation-evoked increases in presynaptic Ca2+ concentration, measured with synaptophysin-GCaMP6f, and of synaptic vesicle exocytosis, measured with synaptophysin-pHlourin, was attenuated in neurons expressing the cGMP scavenger protein sponge (inhibition of exocytosis reduced by 54% for isoflurane and by 53% for sevoflurane). The anesthetic-induced reduction in presynaptic excitability was partially occluded by inhibition of HCN channels, a cGMP-modulated excitatory ion channel that can facilitate glutamate release. We propose that volatile anesthetics depress presynaptic cGMP signaling and downstream effectors like HCN channels that are essential to presynaptic function and excitability. These findings identify novel mechanisms by which volatile anesthetics depress synaptic transmission via second messenger signaling involving the NO/cGMP pathway in hippocampal neurons." @default.
• W4386470026 created "2023-09-07" @default.
• W4386470026 creator A5006974228 @default.
• W4386470026 creator A5040498122 @default.
• W4386470026 creator A5053009782 @default.
• W4386470026 creator A5056426328 @default.
• W4386470026 date "2023-12-01" @default.
• W4386470026 modified "2023-10-15" @default.
• W4386470026 title "Volatile anesthetics inhibit presynaptic cGMP signaling to depress presynaptic excitability in rat hippocampal neurons" @default.
• W4386470026 cites W1145655808 @default.
• W4386470026 cites W1548022409 @default.
• W4386470026 cites W1824110706 @default.
• W4386470026 cites W1974119455 @default.
• W4386470026 cites W1992696758 @default.
• W4386470026 cites W1993385893 @default.
• W4386470026 cites W1999423218 @default.
• W4386470026 cites W2007628754 @default.
• W4386470026 cites W2012818051 @default.
• W4386470026 cites W2013077952 @default.
• W4386470026 cites W2019651658 @default.
• W4386470026 cites W2020491010 @default.
• W4386470026 cites W2022018322 @default.
• W4386470026 cites W2028833397 @default.
• W4386470026 cites W2029452421 @default.
• W4386470026 cites W2036679140 @default.
• W4386470026 cites W2042460710 @default.
• W4386470026 cites W2042850387 @default.
• W4386470026 cites W2043508429 @default.
• W4386470026 cites W2045174528 @default.
• W4386470026 cites W2045613990 @default.
• W4386470026 cites W2046396719 @default.
• W4386470026 cites W2046587306 @default.
• W4386470026 cites W2046868278 @default.
• W4386470026 cites W2051269962 @default.
• W4386470026 cites W2063099205 @default.
• W4386470026 cites W2067623786 @default.
• W4386470026 cites W2070021885 @default.
• W4386470026 cites W2074271273 @default.
• W4386470026 cites W2078283568 @default.
• W4386470026 cites W2090865353 @default.
• W4386470026 cites W2103674001 @default.
• W4386470026 cites W2105867346 @default.
• W4386470026 cites W2114120572 @default.
• W4386470026 cites W2144052707 @default.
• W4386470026 cites W2148527746 @default.
• W4386470026 cites W2148622919 @default.
• W4386470026 cites W2156428325 @default.
• W4386470026 cites W2161530914 @default.
• W4386470026 cites W2328334018 @default.
• W4386470026 cites W2363760440 @default.
• W4386470026 cites W2471925633 @default.
• W4386470026 cites W2475268266 @default.
• W4386470026 cites W2563763139 @default.
• W4386470026 cites W2625623323 @default.
• W4386470026 cites W2727532496 @default.
• W4386470026 cites W2743413137 @default.
• W4386470026 cites W2791585624 @default.
• W4386470026 cites W2791921866 @default.
• W4386470026 cites W2909809735 @default.
• W4386470026 cites W2943731397 @default.
• W4386470026 cites W2953392538 @default.
• W4386470026 cites W3192185029 @default.
• W4386470026 cites W4281783585 @default.
• W4386470026 doi "https://doi.org/10.1016/j.neuropharm.2023.109705" @default.
• W4386470026 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37683886" @default.
• W4386470026 hasPublicationYear "2023" @default.
• W4386470026 type Work @default.
• W4386470026 citedByCount "0" @default.
• W4386470026 crossrefType "journal-article" @default.
• W4386470026 hasAuthorship W4386470026A5006974228 @default.
• W4386470026 hasAuthorship W4386470026A5040498122 @default.
• W4386470026 hasAuthorship W4386470026A5053009782 @default.
• W4386470026 hasAuthorship W4386470026A5056426328 @default.
• W4386470026 hasConcept C112592302 @default.
• W4386470026 hasConcept C170493617 @default.
• W4386470026 hasConcept C173803235 @default.
• W4386470026 hasConcept C178790620 @default.
• W4386470026 hasConcept C185592680 @default.
• W4386470026 hasConcept C2776359302 @default.
• W4386470026 hasConcept C2778162923 @default.
• W4386470026 hasConcept C2778827303 @default.
• W4386470026 hasConcept C2781453256 @default.
• W4386470026 hasConcept C42219234 @default.
• W4386470026 hasConcept C519581460 @default.
• W4386470026 hasConcept C55493867 @default.
• W4386470026 hasConcept C61174792 @default.
• W4386470026 hasConcept C67018056 @default.
• W4386470026 hasConcept C71924100 @default.
• W4386470026 hasConcept C86803240 @default.
• W4386470026 hasConcept C98274493 @default.
• W4386470026 hasConceptScore W4386470026C112592302 @default.
• W4386470026 hasConceptScore W4386470026C170493617 @default.
• W4386470026 hasConceptScore W4386470026C173803235 @default.
• W4386470026 hasConceptScore W4386470026C178790620 @default.
• W4386470026 hasConceptScore W4386470026C185592680 @default.
• W4386470026 hasConceptScore W4386470026C2776359302 @default.
• W4386470026 hasConceptScore W4386470026C2778162923 @default.
• W4386470026 hasConceptScore W4386470026C2778827303 @default.

• next